The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.
Open accessAbstract
Cytokines are recognized as critical early mediators of organ injury. We attempted to determine whether or not severe hepatic ischemia/reperfusion injury results in tumor necrosis factor-alpha (TNF-alpha) release with subsequent local and systemic tissue injury. After 90 min of lobar hepatic ischemia, TNF was measurable during the reperfusion period in the plasma of all 14 experimental animals, with levels peaking between 9 and 352 pg/ml. Endotoxin was undetectable in the plasma of these animals. Pulmonary injury, as evidenced by a neutrophilic infiltrate, edema and intra-alveolar hemorrhage developed after hepatic reperfusion. The neutrophilic infiltrate was quantitated using a myeloperoxidase (MPO) assay; this demonstrated a significant increase in MPO after only 1 h of reperfusion. Anti-TNF antiserum pretreatment significantly reduced the pulmonary MPO after hepatic reperfusion. After a 12-h reperfusion period, there was histologic evidence of intra-alveolar hemorrhage and pulmonary edema. Morphometric assessment showed that pretreatment with anti-TNF antiserum was able to completely inhibit the development of pulmonary edema. Liver injury was quantitated by measuring serum glutamic pyruvic transaminase which showed peaks at 3 and 24 h. Anti-TNF antiserum pretreatment was able to significantly reduce both of these peak elevations. These data show that hepatic ischemia/reperfusion results in TNF production, and that this TNF is intimately associated with pulmonary and hepatic injury.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In a rat model of 90-minute lobar hepatic ischemia/reperfusion, TNF became measurable in plasma in all 14 experimental animals and was associated with subsequent pulmonary and hepatic injury. Pretreatment with anti-TNF antiserum reduced pulmonary neutrophil sequestration, abolished pulmonary edema, and lowered serum SGPT elevations after reperfusion.
Key findings
- After hepatic ischemia/reperfusion, TNF was measurable in plasma of all 14 experimental animals, with a mean peak level of 69.4±30.3 pg/ml and a range of 9–352 pg/ml; TNF was undetectable in sham-operated controls, and endotoxin was undetectable (<5 pg/ml).
- Pulmonary neutrophil sequestration, measured by MPO, peaked after 1 h of reperfusion at 0.653±0.089 U versus 0.213±0.034 U in sham animals (P<0.005). Anti-TNF antiserum reduced MPO to 0.458±0.057 U compared with 0.701±0.040 U in control-serum animals (P<0.005), though it did not return values to sham baseline.
- After 12 h of reperfusion, control-serum animals had 20±4 flooded alveoli/high-power field, whereas anti-TNF antiserum-treated animals had 0±0 (P<0.05 by Wilcoxon rank-sum test).
- Serum SGPT peaked at 3 and 24 h after reperfusion; anti-TNF antiserum significantly reduced both peak elevations (P<0.05 at 3 h and P<0.005 at 24 h versus untreated and control-serum groups). Twenty-four-hour survival was 67% in untreated animals, 92% with anti-TNF antiserum, and 60% with control serum, but the differences were not statistically significant.
Methods
- Adult male pathogen-free Sprague-Dawley rats (200–300 g) underwent 90 min of lobar hepatic ischemia using a Heifitz clip, with sham-operated controls treated identically except for vascular occlusion.
- Plasma TNF activity was measured with a WEHI 164 subclone 13 bioassay; positive samples were confirmed by neutralization with polyclonal rabbit anti-murine TNF antiserum. Endotoxin was measured by a perchloric acid-modified chromogenic limulus assay.
- Organ injury was assessed by pulmonary MPO assay, blinded histologic morphometry of edema-filled alveoli, and serum SGPT. Anti-TNF effects were tested by pretreating rats with polyclonal rabbit anti-murine TNF antiserum versus control rabbit serum. Statistical comparisons used Student Newman-Keuls or Wilcoxon rank-sum tests when data were not normally distributed.
Limitations
- The paper states that 24-h survival differences were not statistically significant, most likely because of relatively small group sizes.
- The paper states that further studies are needed to document the degree to which the observed pulmonary pathology is neutrophil dependent.
- The paper states that the mechanism of TNF induction after hepatic ischemia/reperfusion is not completely clear; the text infers Kupffer cell production/leakage but does not directly establish the cellular source.
- Evident from the text: anti-TNF antiserum did not prevent the transient hypotension after revascularization, so the protective effects observed were not attributable to hemodynamic stabilization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 16 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 90 min of lobar hepatic ischemia, TNF was measurable during the reperfusion period in the plasma of all 14 experimental animals, with levels peaking between 9 and 352 pg/ml.”
- Also stated in: § Results · plain
“TNF was measurable in the plasma of all 14 experimental animals”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Endotoxin was undetectable in the plasma of these animals.”
- Also stated in: § Results · plain
“In addition, endotoxin was unde- tectable (< 5 pg/ml).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“TNF was un- detectable at any time point in the three sham-operated con- trol animals”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The neutrophilic infiltrate was quantitated using a myeloperoxidase (MPO) assay; this demonstrated a significant increase in MPO after only 1 h of reperfusion.”
- Also stated in: § Results · plain
“1 h postrevascularization, mean pulmonary MPO was 0.653±0.089U as compared with 0.213±0.034U for sham-operated animals (P < 0.005; Fig. 3.).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pulmonary injury, as evidenced by a neutrophilic infiltrate, edema and intra-alveolar hemorrhage developed after hepatic reperfusion.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and that a picture of pulmonary neutrophil sequestration and hemorrhagic edema develops.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“of 12 animals treated with anti-TNF antiserum before the induction of hepatic ischemia, 11 animals survived for 24 h, giving a 24-h survival of 92%.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For animals undergoing hepatic ischemia and reperfusion alone, the mean minimum systolic blood was significantly different from sham-operated an- imals (P < 0.005).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of 24 animals undergoing 90 min of lobar hepatic ischemia and 24 h of reperfusion, eight animals ex- pired before 24 h, resulting in a 24-h survival of 67%.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This was not the result of protection from a hypotensive effect, since the anti-TNF and control serum groups showed the same degree of transient hypotension after clamp release.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 17
- The quote only partly states this claim. 3
- Probably not a substantial claim. 7
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean peak TNF level was 69.4±30.3pg/ml with a range of 9-352 pg/ml.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, anti-TNF treatment blunted the increase in pulmonary MPO but did not reduce the MPO level to that observed in sham-operated controls.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MPO levels were maximal after 1 h of reperfusion and gradually decreased over the next 11 h.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“24 h survival in animals treated with control serum was similar to that seen in the untreated experimental group with 6 of 10 animals surviving for 24 h.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
Strength:plain· not yet calibratedn = 10Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the anti-TNF-treated rats illustrate essentially normal histology.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-TNF antiserum pretreatment was able to significantly reduce both of these peak elevations.”
- Also stated in: § Results · plain
“SGPT levels were significantly decreased both 3 and 24 h postrevascularization in the animals treated with anti-TNF antiserum as compared to untreated experimental animals and animals treated with control serum (P < 0.05 after 3 h of reperfusion and”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Statistical significance was not achieved between any of the groups, most likely due to the relatively small numbers in the groups.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > .)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 3 h of hepatic reperfusion, there was a significant decrease in SGPT in animals pretreated with anti-TNF antiserum as compared with both the untreated ex- perimental animals and the control serum-treated animals.”
- Also stated in: § Discussion · hedged
“Animals treated with anti-TNF antiserum showed a significant reduction in a hepatocyte-specific enzyme (SGPT) after hepatic ischemia/reperfusion in comparison to controls treated with control serum”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
- Also stated in: § Discussion · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Anti-TNF antiserum pretreatment significantly reduced the pulmonary MPO after hepatic reperfusion.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the operated rats show intra-alveolar hemorrhage and some edema fluid.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Recent clinical data have shown that impaired hepatic function greatly influences severity and impedes reso- lution of ARDS (4).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
What the sources say
- Not checked yetcites [4]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Since the pulmonary circulation represents the first vascu- lar bed into which these cytokines are delivered, the pulmonary parenchyma would be likely to manifest the toxic effects of these cytokines.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Rests on an assumption: The pulmonary circulation is the first vascular bed into which cytokines from injured liver are delivered.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The lower limit of endotoxin detection in this assay is 5 pg/ml.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The TNF release also did not appear directly related to the hypotensive effect produced by the I/R process, since anti-TNF antiserum treatment blocked the observed pathology, but did not alter the hypotension following clamp release.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“primary nonfunction of the graft after liver transplantation is also associated with the rapid development ofpulmonary insufficiency (5).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Introduction
What the sources say
- Not checked yetcites [5]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The pulmonary pathology appears to be a consequence of TNF, since pretreatment with neutralizing anti-TNF anti- serum blunted the neutrophilic infiltrate (as measured by MPO) and completely abolished both the diffuse edema and patchy hemorrhage.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Slides were examined in a blinded manner.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Myeloperoxidase (MPO) assay. Pulmonary neutrophil sequestra- tion was quantitated with the MPO assay (I14).
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Previous in vitro studies have docu- mented the ability of Kupffer cells to produce TNF (28).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
What the sources say
- Not checked yetcites [28]
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This antiserum neutralizes both natural and recombinant TNF, cross-reacts with rat TNF and has no cross-reactivity with interleukin 1.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
What the sources say
- Not checked yetcites 1 1, 12
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Previous studies have documented a deleterious effect of TNF on the hepatocyte where infused rTNF results in focal hepatic necrosis, as does LPS infusion, and the latter finding could be blocked with anti-TNF antiserum (13).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
What the sources say
- Not checked yetcites [13]
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“However, our model was specifically chosen to avoid such vascular con- gestion, involving only lobar vascular occlusion with unim- peded portal flow to the right lobe.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The three caudal lobes retain an intact portal inflow and venous out- flow, preventing intestinal venous congestion and possible leakage of bacteria or bacterial products into the circulation.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“These data confirm our earlier study which used an intravenous ra- dioactive tracer to document protein leakage into the lungs (9).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Results
What the sources say
- Not checked yetcites [9]
Strength:plain· not yet calibratedn = 5Tests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“By utilizing a rat model of lobar, rather than total, hepatic ischemia, a severe ischemic insult was produced without in- ducing mesenteric venous hypertension (8).”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Methods
What the sources say
- Not checked yetcites [8]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and that TNF has both local deleterious effects on the hepatocyte and extensive damaging effects on pulmonary integrity.”
§ Role of Tumor Necrosis Factor-a in the Pathophysiologic Alterations after Hepatic Ischemia/Reperfusion Injury in the Rat > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
TNF is produced primarily by cells of the monocyte/macrophage lineage.
“TNF is produced primarily by cells of the monocyte/macrophage lineage”
The paper relies on this without support.
The liver Kupffer cell mass is the largest fixed macrophage population in the body.
“the liver Kupffer cell mass is the largest fixed macrophage population in the body.”
The paper relies on this without support.
The pulmonary circulation is the first vascular bed into which cytokines from injured liver are delivered.
“the pulmonary circulation represents the first vascu- lar bed into which these cytokines are delivered”
The paper relies on this without support.
The anti-TNF antiserum used in these experiments neutralizes TNF in vivo and does not have other relevant biological activities that could account for the observed protection.
“pretreatment with neutralizing anti-TNF anti- serum blunted the neutrophilic infiltrate”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reperfusion of ischemic tissues stimulates cytokine overproduction (e.g., TNF, IL-1, HMGB1), which contributes to the pathogenesis of resulting tissue damage (42)(43)(44).”
From Physiology and immunology of the cholinergic antiinflammatory pathway (2007) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Hepatocyte-injury claim cites the Limulus-assay reference
MinorThe discussion cites reference 13 for prior findings about TNF, LPS, and hepatic necrosis, but reference 13 describes a method for the Limulus test rather than those findings.
“Previous studies have documented a deleterious effect of TNF on the hepatocyte where infused rTNF results in focal hepatic necrosis, as does LPS infusion, and the latter finding could be blocked with anti-TNF antiserum (13).”
“13. Obayashi, T. 1984. Addition of perchloric acid to blood sam- ples for colorimetric limulus, test using chromogenic substrate: com- parison with conventional procedures and clinical applications. J. Lab. Clin. Med. 104:321-330.”
Allograft-rejection citation points to a parasitic-infection paper
MinorThe text cites reference 24 for TNF in renal allograft rejection, but reference 24 is titled as a study of parasitic infections. The renal allograft rejection paper appears as reference 25.
“renal allograft rejection (24)”
“24. Scuderi, P., K. E. Sterling, K. S. Lam, P. R. Finley, K. J. Ryan, C. G. Ray, E. Peterson, D. J. Slyman, and S. E. Salmon. 1986. Raised serum levels of tumor necrosis factor in parasitic infections. Lancet. 1:1364-1365.”
Citations
Cites
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,256
Waage, A., Halstensen, A. I., & Espevik, T. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91728-4 · Cited by 1,085
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059
Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,031
Shalaby, M. R., Aggarwal, B. B., Rinderknecht, E., Svedersky, L. P., Finkle, B. S., & Palladino, M. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.2069 · Cited by 916
Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria
Grau, G. E., Taylor, T. E., Molyneux, M. E., Wirima, J. J., VASSALLI, P., Hommel, M., & Lambert, P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906153202404 · Cited by 839
Stimulation of neutrophils by tumor necrosis factor.
Klebanoff, S. J., Vadas, M. A., Harlan, J. M., Sparks, L., Gamble, J. R., Agosti, J. M., & Waltersdorph, A. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4220 · Cited by 832
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Glantz, S. A. 1987. Primer of Biostatistics. 2nd edition.
- Bevilacqua, M. P., J. S. Pober, G. R. Majeau, W. Fiers, R. S. Cotran, and M. A. Gimbrone. 1986. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endo- thelium. Proc. Natl. Acad. Sci. USA. 83:4533-4537.
Cited by
Sorted by citations
Items 101–200 of 821
Uchida, Y., Ke, B., Freitas, M. C. S., Yagita∥, H., Akiba, H., Busuttil, R. W., Najafian, N., & Kupiec‐Weglinski, J. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.003 · Cited by 117
Reperfusion injury to donor livers stored for transplantation
Lemasters, J. J., Bunzendahl, H., & Thurman, R. G. (1995) · Liver Transplantation and Surgery · doi:10.1002/lt.500010211 · Cited by 118
Tumor Necrosis Factor-α in Liver Ischemia/Reperfusion Injury
Perry, B. C., Soltys, D., Toledo, A. H., & Toledo-Pereyra, L. H. (2011) · Journal of Investigative Surgery · doi:10.3109/08941939.2011.568594 · Cited by 117
Reduction of Hepatic Ischemia/Reperfusion Injury by a Soluble P-Selectin Glycoprotein Ligand-1
Dulkanchainun, T. S., Goss, J. A., Imagawa, D. K., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199806000-00006 · Cited by 117
Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury
Llacuna, L., Marı́, M., García‐Ruiz, C., Fernández-Checa, J. C., & Morales, A. (2006) · Hepatology · doi:10.1002/hep.21285 · Cited by 114
TNF-α-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent
Werneburg, N., Guicciardi, M. E., Yin, X., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00019.2004 · Cited by 114
Fernández, L., Heredia, N., Grande, L., Gómez, G., Rimola, A., Marco, A. J., Gelpı́, E., Roselló‐Catafau, J., & Peralta, C. (2002) · Hepatology · doi:10.1053/jhep.2002.34616 · Cited by 112
Liver Ischemia: Apoptosis as a Central Mechanism of Injury
Rüdiger, H. A., Graf, R., & Clavien, P. (2003) · Journal of Investigative Surgery · doi:10.1080/08941930390205764 · Cited by 112
“For example, we have demonstrated that apoptotic cell death is initiated by binding of tumor necrosis factor α (TNFα) to the specific receptor TNF-R1 on the cell membrane of hepatocytes in a mouse model of normothermic ischemic injury [20] (Figure 2).”
BackgroundInfluentialInhibition of Kupffer Cells Reduced CXC Chemokine Production and Liver Injury
Mosher, B. D., Dean, R. E., Harkema, J. R., Remick, D. G., Palma, J., & Crockett, E. T. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6217 · Cited by 112
Self-citationCurrent status of ischemia and reperfusion injury in the liver
Farmer, D. G., Amersi, F. F., Kupiec‐Weglinski, J. W., & Busuttil, R. W. (2000) · Transplantation Reviews · doi:10.1053/tr.2000.4651 · Cited by 110
Zimmerman, G. A., Meistrell, M. E., Bloom, O., Cockroft, K. M., Bianchi, M., Risucci, D. A., Broome, J., Farmer, P., Cerami, A., & Vlassara, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3744 · Cited by 111
Tumor Necrosis Factor and Alcoholic Liver Disease
McClain, C. J., Barve, S. S., Joshi‐Barve, S., Deaciuc, I. V., & Hill, D. B. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04011.x · Cited by 103
Moine, O. L., Louis, H., Demols, A., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.7881 · Cited by 110
Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice
Sakai, N., Sweringen, H. L. V., Quillin, C. R., Schuster, R. M., Blanchard, J. A., Burns, J. M., Tevar, A. D., Edwards, M. J., & Lentsch, A. B. (2012) · Hepatology · doi:10.1002/hep.25768 · Cited by 111
“The subacute phase of injury is initiated by inflammatory mediators, including interleukin (IL)-12/23, tumor necrosis factor alpha (TNF-a), and IL-1, released by activated Kupffer cells and hepatocytes.(5-8) These mediators lead to the expression of CXC chemokines and adhesion molecules, which recruit activated neutro…”
BackgroundPost-ischaemic organ dysfunction: A review
Homer‐Vanniasinkam, S., Crinnion, J. N., & Gough, M. J. (1997) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(97)80191-8 · Cited by 108
Ogiku, M., Kono, H., Hara, M., Tsuchiya, M., & Fujii, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182592 · Cited by 107
“…characterized by the activation of Kupffer cells, their production of reactive oxygen species (Jaeschke, 1999), and the release of proinflammatory chemokines and cytokines, including interleukin-12 and tumor necrosis factor (Colletti et al.,1990; Lentsch et al., 1999; Rüdiger and Clavien, 2002).”
BackgroundJiao, S., Sun, K., Chen, X., Zhao, X., Cai, N., Liu, Y., Xu, L., Kong, X., & Wei, L. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-1 · Cited by 107
“Furthermore, development of IR has been shown to cause a remarkable increase in the serum level of tumor necrosis factor alpha (TNF-α), mainly through release from activated Kupffer cells [9,10].”
BackgroundResultLentsch, A. B., Yoshidome, H., Kato, A., Warner, R. L., Cheadle, W. G., Ward, P. A., & Edwards, M. J. (1999) · Hepatology · doi:10.1002/hep.510300615 · Cited by 105
Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs.
Seekamp, A., Mulligan, M. S., Till, G. O., et al. (1993) · PubMed · Cited by 106
Sindram, D., Porte, R. J., Hoffman, M., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0554fje · Cited by 105
Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity
Woolbright, B. L., & Jaeschke, H. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0147-0 · Cited by 104
Kuboki, S., Shin, T., Huber, N., Eismann, T., Galloway, E., Schuster, R. M., Blanchard, J. A., Edwards, M. J., & Lentsch, A. B. (2008) · Hepatology · doi:10.1002/hep.22471 · Cited by 104
Treatment With Glutathione Precursor Decreases Cytokine Activity
Peña, L., Hill, D. B., & McClain, C. J. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719902300101 · Cited by 104
Ke, B., Shen, X., Ji, H., Kamo, N., Gao, F., Freitas, M. C. S., Busuttil, R. W., & Kupiec‐Weglinski, J. W. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.023 · Cited by 103
“Activated Kupffer cells release superoxide radicals, TNF-a and IL-1, which promote NF-jB activation, and recruitment of activated CD4+ T cells into the liver [5–7].”
Pruitt, J. H., Welborn, M. B., Edwards, P., Harward, T. R. S., Seeger, J., Martin, T., Smith, C. A., Kenney, J. P., Wesdorp, R. I. C., Meijer, S., et al. (1996) · PubMed · doi:10.1182/blood.v87.8.3282.bloodjournal8783282 · Cited by 100
Jiang, H., Meng, F., Wei, L., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.03.024 · Cited by 102
Gadina, M., Bertini, R., Mengozzi, M., et al. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.6.1305 · Cited by 102
Rogy, M. A., Auffenberg, T., Espat, N. J., Philip, R., Remick, D. G., Wollenberg, G. K., Copeland, E. M., & Moldawer, L. L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2289 · Cited by 102
“5 h after the endotoxin challenge, the mice were killed, and lungs were removed for TNF-c~ content and neutrophil infiltration, as measured by myeloperoxidase levels ( 20 ).”
MethodSelf-citationSIGNIFICANCE OF EARLY AMINOTRANSFERASE ELEVATION AFTER LIVER TRANSPLANTATION1
Rosen, H. R., Martin, P. B., Goss, J. A., et al. (1998) · Transplantation · doi:10.1097/00007890-199801150-00013 · Cited by 101
Eckhoff, D. E., Bilbao, G., Frenette, L., et al. (2002) · Surgery · doi:10.1067/msy.2002.125718 · Cited by 101
Oxidative stress and acute hepatic injury
Ramachandran, A., & Jaeschke, H. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.10.011 · Cited by 100
de LeBlanc, A. D. M., Castillo, N. A., & Perdigón, G. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.01.020 · Cited by 98
Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass
Martínez-Pellús, A., Bru, M., Seller, G., Fuentes, T., Merino, P., Canovas, J., Sapiña, J., & Moro, J. (1997) · Intensive Care Medicine · doi:10.1007/s001340050494 · Cited by 95
“Detection of TNF and interleukins in the plasma may reflect a sequential phenomenon triggered by endotoxin [27-29].”
BackgroundTeoh, N., Field, J., Sutton, J., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20035 · Cited by 96
Specific Role of Interleukin-1 in Hepatic Neutrophil Recruitment after Ischemia/Reperfusion
Kato, A., Gabay, C., Okaya, T., & Lentsch, A. B. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64456-2 · Cited by 98
“Similar to other acute inflammatory responses, a central role of TNF- has been demonstrated in hepatic ischemia/reperfusion injury.(8) Numerous studies have demonstrated that TNF- is the primary intercellular stimulus for the production of CXC chemokines and up-regulation of vascular cell adhesion molecules.”
BackgroundSun, C., Chang, C.-L., Lin, Y., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823dae23 · Cited by 96
“The early phase, which occurs 0–4 hrs post-IR, involves Kupffer cell activation that results in morphologic changes (23), priming, the release of reactive oxygen species (24), and proinflammatory cytokines such as TNF- (25) and IL-1 (26).”
BackgroundInfluentialReciprocal Activation Between CD4+ T Cells and Kupffer Cells During Hepatic Ischemia-Reperfusion
Hanschen, M., Zahler, S., Krombach, F., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e3181821aa7 · Cited by 96
“As well known, Kupffer cells are activated during I/R (13, 30), release proinflammatory mediators (31, 32) and account for oxidative stress during reperfusion (33).”
BackgroundIntracellular survival pathways in the liver
Luedde, T., & Trautwein, C. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01366.x · Cited by 95
Yang, M., Antoine, D. J., Weemhoff, J. L., Jenkins, R. E., Farhood, A. I., Park, K. B., & Jaeschke, H. (2014) · Liver Transplantation · doi:10.1002/lt.23958 · Cited by 101
Nardone, G., Compare, D., Liguori, E., Mauro, V., Rocco, A., Barone, M., Napoli, A., Lapi, D., Iovene, M. R., & Colantuoni, A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00188.2010 · Cited by 94
Teoh, N. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06584.x · Cited by 92
Seifert, J. K., France, M. P., Zhao, J., et al. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6139-5 · Cited by 93
“hemorrhagic shock [21] or ischemia-reperfusion liver injury [ 27 ], causing pulmonary injury.”
BackgroundInfluentialNELSON, S., WONG, G., & McCord, J. M. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80021-1 · Cited by 93
Recovery of hepatocellular ATP and “pericentral apoptosis” after hemorrhage and resuscitation
Paxian, M., Bauer, I., Rensing, H., Jaeschke, H., Mautes, A. E. M., Kolb, S., Wolf, B., STOCKHAUSEN, A., JEBLICK, S., & Bauer, M. W. (2003) · The FASEB Journal · doi:10.1096/fj.02-0624com · Cited by 90
“Thus, characterization of the mechanisms underlying hepatocellular injury is of particular importance since treatment strategies such as inhibition of caspase activity may offer novel pharmacological tools to prevent hepatocellular dysfunction and ultimately multiple organ failure (MOF) in critically ill patients (4,…”
BackgroundSerizawa, A., Nakamura, S., Suzuki, S., Baba, S., & Nakano, M. (1996) · Hepatology · doi:10.1002/hep.510230649 · Cited by 91
Wheeler, M. D., Yamashina, S., Froh, M., et al. (2001) · PubMed · Cited by 91
Protection of the liver during hepatic surgery
Clavien, P., Emond, J. C., Vauthey, J., Belghiti, J., Chari, R. S., & Strasberg, S. M. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.12.006 · Cited by 90
Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis
Arai, M., Mochida, S., Ohno, A., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90357-i · Cited by 90
Toll-Like Receptors, Tissue Injury, and Tumourigenesis
Ioannou, S., & Voulgarelis, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/581837 · Cited by 91
“After hepatic ischemia-reperfusion, wild-type but not TLR4mutant dendritic cells displayed a strong increase of TNFα production [27], a well-known mediator of hepatic ischemia-reperfusion injury that is rapidly and potently released from macrophages and DC following TLR activation [28, 29].”
BackgroundAGE-DEPENDENT RESPONSES TO HEPATIC ISCHEMIA/REPERFUSION INJURY
Okaya, T., Blanchard, J. A., Schuster, R. M., Kuboki, S., Husted, T. L., Caldwell, C. C., Zingarelli, B., Wong, H. R., Solomkin, J. S., & Lentsch, A. B. (2005) · Shock · doi:10.1097/01.shk.0000181282.14050.11 · Cited by 92
Cerebroprotective Effects of Aminoguanidine in a Rodent Model of Stroke
Cockroft, K. M., Meistrell, M. E., Zimmerman, G. A., Risucci, D. A., Bloom, O., Cerami, A., & Tracey, K. J. (1996) · Stroke · doi:10.1161/01.str.27.8.1393 · Cited by 87
Hill, D. B., Barve, S. S., Joshi‐Barve, S., & McClain, C. J. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.106451 · Cited by 84
The Protective Mechanism of Ligustrazine Against Renal Ischemia/Reperfusion Injury
Li, F., Ke, N., Cheng, F., Guo, Y., Li, S., Li, Q., & Li, Y. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.04.005 · Cited by 87
Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytotoxicity
Neuman, M. G., Cameron, R., Haber, J. A., Katz, G. G., Malkiewicz, I. M., & Shear, N. H. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00052-1 · Cited by 87
Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure
Rodrigues, S. F., & Granger, D. N. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq090 · Cited by 91
Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes.
Koga, S., Ogawa, S., Kuwabara, K., Brett, J., Leavy, J. A., Ryan, J., Koga, Y., Plocinski, J. M., Benjamin, W. R., & Burns, D. K. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115913 · Cited by 86
Role of Reactive Oxygen Species in Hepatic Ischemia-Reperfusion Injury and Preconditioning
Jaeschke, H. (2003) · Journal of Investigative Surgery · doi:10.1080/08941930390205773 · Cited by 85
“Generation of proinflammatory cytokines (TNF-α, IL-1) and chemokines (IL-8, MIP-2, KC) are dependent on NF-κB activation in Kupffer cells and hepatocytes.”
BackgroundInfluentialTakeuchi, D., Yoshidome, H., Kato, A., Ito, H., Kimura, F., Shimizu, H., Ohtsuka, M., Morita, Y., & Miyazaki, M. (2004) · Hepatology · doi:10.1002/hep.20117 · Cited by 84
Lentsch, A. B., Yoshidome, H., Warner, R. L., Ward, P. A., & Edwards, M. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70355-0 · Cited by 82
Post-liver transplantation myocardial dysfunction
Sampathkumar, P., Lerman, A., Kim, B. Y., et al. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040513 · Cited by 84
Inflammation and Platelet–Activating Factor Production During Hepatic Ischemia/Reperfusion
Zhou, W., McCollum, M. O., Levine, B. A., & Olson, M. S. (1992) · Hepatology · doi:10.1002/hep.1840160521 · Cited by 84
Jiang, N. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i29.4694 · Cited by 83
DeCicco, L. A., Rikans, L. E., Tutor, C. G., et al. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00110-6 · Cited by 83
Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., Yin, X., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.022 · Cited by 81
Distinct contributions of CD4+T cell subsets in hepatic ischemia/reperfusion injury
Kuboki, S., Sakai, N., Tschöp, J., Edwards, M. J., Lentsch, A. B., & Caldwell, C. C. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90464.2008 · Cited by 81
Syk, I., Brunkwall, J. S., Ivancev, K., et al. (1998) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/s1078-5884(98)80200-1 · Cited by 82
Activation of Interleukin-6/STAT3 and Liver Regeneration Following Transplantation
Debonera, F., Aldeguer, X., Shen, X., Gelman, A. E., Gao, F., Que, X., Greenbaum, L. E., Furth, E. E., Taub, R. A., & Olthoff, K. M. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6086 · Cited by 79
Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion
Kim, K., Li, Y., Jin, G., Chong, W., Liu, B., Lu, J., Lee, K., DeMoya, M. A., Velmahos, G. C., & Alam, H. B. (2011) · Resuscitation · doi:10.1016/j.resuscitation.2011.07.029 · Cited by 81
“IL-6 is one of potent proinflammatory cytokines and exerts toxic action on target cells in ischemia/reperfusion [24].”
Arumugam, T. V. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.017 · Cited by 81
“The pro-inflammatory cytokine, TNFa, is commonly measured in hepatic I/R as a marker of tissue injury [43].”
BackgroundHigh levels of portal TNF-α during abdominal aortic surgery in man
Cabie, A., Farkas, J.-C., Fitting, C., et al. (1993) · Cytokine · doi:10.1016/1043-4666(93)90034-3 · Cited by 81
Goto, M., Takei, Y., Kawano, S., Tsuji, S., Fukui, H., Fushimi, H., Nishimura, Y., Kashiwagi, T., Fusamoto, H., & Kamada, T. (1992) · Hepatology · doi:10.1002/hep.1840160230 · Cited by 76
Is Ischemic Preconditioning a Useful Strategy in Steatotic Liver Transplantation?
Fernández, L., Carrasco-Chaumel, E., Serafin, A. M., Xaus, C., Grande, L., Rimola, A., Roselló‐Catafau, J., & Peralta, C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00447.x · Cited by 80
“TNF release from the nonsteatotic liver into systemic circulation during reperfusion is believed to be responsible for the lung damage associated with liver transplantation (7).”
BackgroundBiological modulation of liver ischemia–reperfusion injury
de Rougemont, O., Dutkowski, P., & Clavien, P. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283373ced · Cited by 80
Hemodynamic Correlates of Outcome in Patients Undergoing Orthotopic Liver Transplantation
Nasraway, S. A., Klein, R. D., Spanier, T. B., et al. (1995) · CHEST Journal · doi:10.1378/chest.107.1.218 · Cited by 79
Secondary Organ Dysfunction: From Clinical Perspectives to Molecular Mediators
Cipolle, M. D., Pasquale, M. D., & Cerra, F. B. (1993) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30196-9 · Cited by 79
Teoh, N., Field, J., & Farrell, G. C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.039 · Cited by 78
Kuboki, S., Shin, T., Huber, N., Eismann, T., Galloway, E., Schuster, R. M., Blanchard, J. A., Zingarelli, B., & Lentsch, A. B. (2007) · Hepatology · doi:10.1002/hep.21963 · Cited by 78
Evidence against an increase in capillary permeability in subjects exposed to high altitude
Kleger, G., Bärtsch, P., Vock, P., et al. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.5.1917 · Cited by 77
Advances in the regulation of liver regeneration
Jia, C. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.87 · Cited by 75
Role of IL-17A in Neutrophil Recruitment and Hepatic Injury after Warm Ischemia–Reperfusion Mice
Kono, H., Fujii, H., Ogiku, M., Hosomura, N., Amemiya, H., Tsuchiya, M., & Hara, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100490 · Cited by 77
“TNF-a has been produced by Kupffer cells within the early phases of ischemic liver injury before reperfusion and implicated in amplification of subsequent neutrophil inflammatory responses (4, 8, 29).”
BackgroundThe impact of sterile inflammation in acute liver injury
Woolbright, B. L. (2017) · Journal of Clinical and Translational Research · doi:10.18053/jctres.03.2017s1.003 · Cited by 79
“continued inflammation and injury [41,118-120,128,129].”
Functional spectrum of sinusoidal endothelial liver cells
Rieder, H., Büschenfelde, K.-H. M. Z., & Ramadori, G. P. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90042-n · Cited by 77
Zhou, W., Zhang, Y., Hosch, M. S., Lang, A., Zwacka, R. M., & Engelhardt, J. F. (2001) · Hepatology · doi:10.1053/jhep.2001.23073 · Cited by 78
Kokura, S., Wolf, R. E., Yoshikawa, T., Granger, D. N., & Aw, T. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.2.205 · Cited by 76
Nuclear Factor Interleukin 6 Motifs Mediate Tissue-specific Gene Transcription in Hypoxia
Yan, S., Zou, Y. S., Mendelsohn, M. M., Gao, Y. J., Naka, Y., Yan, S. D., Pinsky, D. J., & Stern, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4287 · Cited by 77
Kiemer, A. K., Vollmar, A. M., Bilzer, M., Gerwig, T., & Gerbes, A. L. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80364-5 · Cited by 77
Role of nitric oxide in the oxidant stress during ischemia/reperfusion injury of the liver
Jaeschke, H., Schini‐Kerth, V. B., & Farhood, A. I. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90064-v · Cited by 76
Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients
Wan, S., LeClerc, J.-L., Schmartz, D., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70229-1 · Cited by 76
Modulation of ischemia-reperfusion-induced hepatic injury by kupffer cells
Shiratori, Y., Kiriyama, H., Fukushi, Y., et al. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02093792 · Cited by 76
“Recently, reperfusion-induced hepatic injury following cold ischemia has been found to activate Kupffer cells and to enhance the activity of tumor necrosis factor in the circulation, leading to liver injury ( 8 ).”
BackgroundGatti, S., Faggioni, R., Echtenacher, B., et al. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05924.x · Cited by 75
Kuboki, S., Okaya, T., Schuster, R. M., Blanchard, J. A., Denenberg, A. G., Wong, H. R., & Lentsch, A. B. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00186.2006 · Cited by 74
“Therefore, we examined serum levels of TNF- after 1 h of reperfusion, a time at which we and others have shown that serum TNF- is maximal (6, 25).”
BackgroundMethodFan, C., Li, Q., Zhang, Y., Liu, X., Luo, M., Abbott, D., Zhou, W., & Engelhardt, J. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17337 · Cited by 75
Shirasugi, N., Wakabayashi, G., Shimazu, M., Oshima, A., Shito, M., Kawachi, S., Karahashi, T., Kumamoto, Y., Yoshida, M., & Kitajima, M. (1997) · Transplantation · doi:10.1097/00007890-199711270-00004 · Cited by 73
Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury
Demir, S., & İnal-erden, Ṁ. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00078-3 · Cited by 74
Bradham, C. A., Schemmer, P., Stachlewitz, R. F., Thurman, R. G., & Brenner, D. A. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050401 · Cited by 74
Thornton, A. J., Ham, J. M., & Kunkel, S. L. (1991) · Hepatology · doi:10.1002/hep.1840140627 · Cited by 74
Self-citationYAMAGATA, K., TAGAMI, M., TAKENAGA, F., YAMORI, Y., & ITOH, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.001 · Cited by 73
Hepatic Ischemia–Reperfusion Promotes Liver Metastasis of Colon Cancer
Doi, K., Horiuchi, T., Uchinami, M., et al. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6356 · Cited by 73
“5 to 1 h after ischemia [6, 36].”
BackgroundRole of nitric oxide in liver ischemia and reperfusion injury
Hines, I. N., Kawachi, S., Harada, S., Pavlick, K. P., Hoffman, J. M., Bharwani, S., Wolf, R. E., & Grisham, M. B. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1087-1_27 · Cited by 73
Cytokine Cascades and the Hepatic Inflammatory Response to Ischemia and Reperfusion
Okaya, T., & Lentsch, A. B. (2003) · Journal of Investigative Surgery · doi:10.1080/08941930390205782 · Cited by 71
“Hepatic vascular expression of ICAM-1 is also increased by TNFα, and blockade of TNFα attenuates neutrophil accumulation and subsequent liver injury [21, 23].”
Background
Metadata
- Authors
- Colletti, L. M., Remick, D. G., Burtch, G. D., Kunkel, S. L., Strieter, R. M., & Campbell, D. A.
- Affiliations
- University of Michigan (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1990-06-01
- Volume
- 85
- Issue
- 6
- Pages
- 1936-1943
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC296661
- OpenAlex
- W2099883737
- Semantic Scholar
- ef00ab3fc75d2591f58ef3691dd24619b03cf25e
- Cited by
- 817
- References
- 43
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 16 · 2017: 12 · 2016: 6 · 2015: 15 · 2014: 12 · 2013: 20 · 2012: 24
- FWCI
- 40.45
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl031237-32)
- National Heart, Lung, and Blood Institute (HL-35276, HL31237, HL 31963, P01HL031963)
- Topics
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- TNF-α, hepatic ischemia-reperfusion injury, cytokines, pulmonary edema, intra-alveolar hemorrhage, neutrophil infiltration, myeloperoxidase, liver injury, systemic inflammatory response, endotoxin
- MeSH terms
- Alanine Transaminase, Animals, Hemodynamics, Ischemia, Liver, Liver Diseases, Lung, Peroxidase, Neutrophils, Time Factors, Tumor Necrosis Factor-alpha, Reperfusion Injury, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
